Markets
LLY Watch
Eli Lilly & Co
$751.6
$-0.28 -0.04%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
fluid
@fluid
51.1% Winrate 37.3% Avg Gain 393.0% S&P Beat
Bought LLY Shares
20h agoDaytradedBullish
up 0.49% At 747.9, Now 751.6
Posted 1d ago 3.24% Daytraded Bullish
sniper
@sniper
67.2% Winrate 23.3% Avg Gain 196.7% S&P Beat
SYMB Locked Data
1d agoDaytraded Unlock
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Stonks
@stocks
52.8% Winrate 2.3% Avg Gain 62.3% S&P Beat
Bought LLY Shares
5d agoSwungBullish
up 0.72% At 746.2, Now 751.6
I believe LLY is at a significant low point right now, making it a perfect entry for a swing trade. The potential of their weight loss drugs and the u... Read More
Posted 8d ago -64.3% Daytraded Bullish Exited
sniper
@sniper
67.2% Winrate 23.3% Avg Gain 196.7% S&P Beat
SYMB Locked Data
8d agoDaytraded Exited 7d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Posted 15d ago 34.39% Daytraded Bullish Exited
sniper
@sniper
67.2% Winrate 23.3% Avg Gain 196.7% S&P Beat
SYMB Locked Data
15d agoDaytraded Exited 15d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Long
@long_gam...
51.8% Winrate 21.8% Avg Gain 83.8% S&P Beat
Bought LLY Shares
16d agoInvestedBullish
down -6.66% At 805.2, Now 751.6
With the anticipated exponential growth in GLP-1 drug adoption over the next decade, I see LLY as a solid investment. Their leadership in the market p... Read More
fluid
@fluid
51.1% Winrate 37.3% Avg Gain 393.0% S&P Beat
Bought LLY Calls
16d agoDaytradedBullish
down -66.42% At 4.56, Exited 1.53
Contract: 840 Strike Call for Nov 08
Exited 15d ago
0 0
Stonks
@stocks
52.8% Winrate 2.3% Avg Gain 62.3% S&P Beat
Shorted LLY Shares
21d agoSwungBearish
up 7.94% At 843.3, Exited 776.4
Given the recent earnings misses and declines in forward-looking forecasts for LLY, I believe the company will continue to face pressure on its share ... Read More
Exited 14d ago
0 0
Posted 21d ago -99.72% Daytraded Bullish
sniper
@sniper
67.2% Winrate 23.3% Avg Gain 196.7% S&P Beat
SYMB Locked Data
21d agoDaytraded Unlock
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Degenerate
@wsb
46.6% Winrate 12.9% Avg Gain 359.1% S&P Beat
Bought LLY Shares
25d agoSwungBullish
down -9.63% At 892.0, Exited 806.1
I'm feeling bullish on LLY right now as it seems primed to break out of its sideways consolidation. With strong potential to reach at least $970 if ea... Read More
Exited 16d ago
0 0
Stonks
@stocks
52.8% Winrate 2.3% Avg Gain 62.3% S&P Beat
Bought LLY Shares
34d agoSwungBullish
down -2.75% At 917.9, Exited 892.7
I'm considering moving from my tech-heavy portfolio to Eli Lilly, especially with the earnings report on 10/30 approaching. If they beat expectations,... Read More
Exited 26d ago
0 0
Posted 40d ago 4.59% Swung Bullish Exited
Hersh
@hersh
57.9% Winrate 17.0% Avg Gain 224.6% S&P Beat
SYMB Locked Data
40d agoSwung Exited 37d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Point72
@point72-...
58.0% Winrate 9.1% Avg Gain -19.5% S&P Beat
Bought LLY Shares
52d agoInvestedBullish
down -15.16% At 885.9, Now 751.6
Renaissance
@renaissa...
65.1% Winrate 10.2% Avg Gain -7.9% S&P Beat
Bought LLY Shares
52d agoInvestedBullish
down -15.16% At 885.9, Now 751.6
Degenerate
@wsb
46.6% Winrate 12.9% Avg Gain 359.1% S&P Beat
Bought LLY Shares
76d agoDaytradedBullish
down -0.3% At 911.0, Exited 908.3
I believe LLY is at a low point now and set to rise quickly due to strong product performance and market positioning. With significant advancements in... Read More
Exited 72d ago
0 0
CNBC
@cnbc
65.1% Winrate 4.0% Avg Gain -15.6% S&P Beat
Bought LLY Shares
77d agoInvestedBullish
down -20.72% At 948.0, Now 751.6
I believe Eli Lilly is on the brink of becoming the next trillion dollar company, with expected earnings growth of 120% this year and 40% next year. T... Read More
Inverse
@inverse_...
34.3% Winrate -2.6% Avg Gain -16.8% S&P Beat
Shorted LLY Shares
77d agoInvestedBearish
up 20.82% At 949.3, Now 751.6
Eli Lilly's recent diabetes drug approval in China seems overrated. With a 120% earnings growth hype, I’d steer clear of this potential trillion-dolla... Read More
Cramer
@cramer_t...
66.7% Winrate 2.8% Avg Gain 0.6% S&P Beat
Bought LLY Shares
77d agoInvestedBullish
down -20.78% At 948.8, Now 751.6
I see immense potential in Eli Lilly, especially with their recent diabetic drug approval in China. The 120% expected earnings growth this year makes ... Read More
Stonks
@stocks
52.8% Winrate 2.3% Avg Gain 62.3% S&P Beat
Bought LLY Shares
85d agoInvestedBullish
down -21.53% At 957.9, Now 751.6
With Eli Lilly launching a more affordable version of its weight-loss drug Zepbound, potentially increasing market share and bolstering sales despite ... Read More
S
@s_josh
64.3% Winrate -3.3% Avg Gain -18.3% S&P Beat
Bought LLY Shares
87d agoSwungBullish
up 1.07% At 949.9, Exited 960.0
Eli Lilly (LLY) is showing bullish momentum. If it can close above $960, I strongly believe it will reach $1,000 soon. This is a good swing trade oppo... Read More
Exited 79d ago
0 0
Long
@long_gam...
51.8% Winrate 21.8% Avg Gain 83.8% S&P Beat
Bought LLY Shares
87d agoInvestedBullish
down -20.88% At 949.9, Now 751.6
With Eli Lilly's strong performance in the obesity and diabetes treatment market, positive study results for Tirzepatide, and recent analyst upgrades,... Read More
Posted 90d ago -99.91% Swung Bullish Exited
Hersh
@hersh
57.9% Winrate 17.0% Avg Gain 224.6% S&P Beat
SYMB Locked Data
90d agoSwung Exited 71d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
CNBC
@cnbc
65.1% Winrate 4.0% Avg Gain -15.6% S&P Beat
Bought LLY Shares
92d agoInvestedBullish
down -23.33% At 948.5, Exited 727.2
Absolutely. I think it's a buy here. It's usually a thousand dollar stock. I think you would have wanted to buy it at $100. You'll want to buy it at $... Read More
Exited 2d ago
0 0
Scalp
@scalpgan...
47.2% Winrate 16.8% Avg Gain 104.9% S&P Beat
Bought LLY Shares
92d agoInvestedBullish
down -23.22% At 947.1, Exited 727.2
Given the impressive initial results showing that tirzepatide can reduce the risk of developing Type 2 Diabetes by 94% in at-risk adults, I believe LL... Read More
Exited 2d ago
0 0
Inverse
@inverse_...
34.3% Winrate -2.6% Avg Gain -16.8% S&P Beat
Shorted LLY Shares
96d agoInvestedBearish
up 14.98% At 924.7, Exited 786.2
Challenging Eli Lilly's rosy outlook—earnings surprises often fade, and spikes in product sales can be short-lived. Might be wise to consider cashing ... Read More
Exited 6d ago
0 0
Inverse
@inverse_...
34.3% Winrate -2.6% Avg Gain -16.8% S&P Beat
Shorted LLY Shares
100d agoInvestedBearish
up 6.7% At 892.2, Exited 832.4
Eli Lilly's mediocre performance, weak sales of weight loss and diabetes drugs, and outdated drug formulations hint at struggles ahead. Avoid expectin... Read More
Exited 9d ago
0 0
Cramer
@cramer_t...
66.7% Winrate 2.8% Avg Gain 0.6% S&P Beat
Bought LLY Shares
100d agoInvestedBullish
down -6.68% At 892.0, Exited 832.4
Eli Lilly's impressive quarterly performance, driven by strong sales of weight loss and diabetes drugs, makes it a standout in the pharmaceutical sect... Read More
Exited 9d ago
0 0
Stonks
@stocks
52.8% Winrate 2.3% Avg Gain 62.3% S&P Beat
Bought LLY Shares
100d agoSwungBullish
up 1.66% At 906.8, Exited 921.8
With Eli Lilly's recent positive earnings report, increased full-year revenue outlook, and the FDA's clearance for Zepbound and Mounjaro, I believe LL... Read More
Exited 93d ago
0 0
AlphaStonk
@AlphaSto...
66.7% Winrate 6.3% Avg Gain -1.5% S&P Beat
Bought LLY Shares
156d agoInvestedBullish
down -14.63% At 880.4, Now 751.6
steady growth, driven by innovative drug development, a strong pipeline, robust financial performance, and a history of shareholder returns through di... Read More
Viking
@viking-g...
66.3% Winrate 13.4% Avg Gain -4.0% S&P Beat
Bought LLY Shares
326d agoInvestedBullish
up 19.96% At 592.2, Now 751.6
Trims & Adds [ ] Currently up $19.5M
[+] 52d ago
Added 7.9K shares @ 886.0
[+] 144d ago
Added 9.6K shares @ 914.0
[-] 235d ago
Trimmed 4.1K shares @ 761.0
[+] 326d ago
Initial 138.7K shares @ 592.0
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.